Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Oncology | Gastroenterology | Family Medicine
Colon Cancer Clinical Trials
A listing of Colon Cancer medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.
California
Duarte : City of Hope
A Phase II Trial of Radioimmunotherapy (Y-90 M5A) Following Hepatic Resection and FOLFIRI or FOLFOX Chemotherapy [+/-BEVACIZUMAB], or Xelox for Metastatic Colorectal Carcinoma to the Liver
Duarte : City of Hope
A Prospective Study for the Assessment of Recurrence Risk in Stage II Colon Cancer Patients Using ColoPrint
Duarte : City of Hope
CALGB/SWOG C80702: A Phase III Trial of 6 Versus 12 Treatments of Adjuvant FOLFOX Plus Celecoxib or Placebo for Patients with Resected Stage III Colon Cancer
Duarte : City of Hope
Evaluation of Colon/Rectal Cancer Patterns and Outcomes of Care
Duarte : City of Hope
Protocol I4T-MC-JVBB (also known as IMCL CP12-0920) A Randomized, Double-Blind, Multicenter Phase 3 Study of Irinotecan, Folinic Acid, and 5-Fluorouracil (FOLFIRI) Plus Ramcirumab or Placebo in Patients with Metastatic Colorectal Carcinoma Progressive During or Following First-Line Combination Therapy with Bevacizumab, Oxaliplatin, and a Fluoropyrimidine
Duarte : City of Hope
Randomised Comparative Study of FOLFOX6m Plus SIR-Spheres Microspheres Versus FOLFOX6m Alone as First Line Treatment in Patients with Non-Resectable Liver Metastases from Primary Colorectal Carcinoma
Duarte : City of Hope
Survivorship Care Planning in Colorectal and Lung Cancer: A Feasibility Study
View More »
Glendale : Glendale Memorial Hospital
A Prospective Study for the Assessment of Recurrence Risk in Stage II Colon Cancer Patients Using ColoPrint
Laguna Hills : South Orange County Surgical Medical Group
A Prospective Study for the Assessment of Recurrence Risk in Stage II Colon Cancer Patients Using ColoPrint
Long Beach : Long Beach Memorial Medical Center
A Prospective Study for the Assessment of Recurrence Risk in Stage II Colon Cancer Patients Using ColoPrint
Roseville : Sutter Roseville Medical Center /Research
A Prospective Study for the Assessment of Recurrence Risk in Stage II Colon Cancer Patients Using ColoPrint
Sacramento : UC Davis Cancer Center
A Prospective Study for the Assessment of Recurrence Risk in Stage II Colon Cancer Patients Using ColoPrint
Sacramento : Sutter Cancer Center
A Prospective Study for the Assessment of Recurrence Risk in Stage II Colon Cancer Patients Using ColoPrint
Stanford : Stanford University School of Medicine
Perfusion CT as a Predictor of Treatment Response in Patients With Hepatic Malignancies
Colorado
Aurora : University of Colorado Cancer Center
A Prospective Study for the Assessment of Recurrence Risk in Stage II Colon Cancer Patients Using ColoPrint
Connecticut
New Haven : Yale Cancer Center
A Prospective Study for the Assessment of Recurrence Risk in Stage II Colon Cancer Patients Using ColoPrint
District of Columbia
Washington : Georgetown University
A Pilot Trial of GI-4000 Plus Bevacizumab and Either FOLOFOX or FOLFIRI
Washington : Georgetown University Hospital
A Prospective Study for the Assessment of Recurrence Risk in Stage II Colon Cancer Patients Using ColoPrint
Florida
Miami : University of Miami
A Prospective Study for the Assessment of Recurrence Risk in Stage II Colon Cancer Patients Using ColoPrint
Georgia
Savannah : Memorial University Medical Center
CALGB 80702: A Phase III trial of 6 versus 12 Treatments of Adjuvant FOLFOX plus Celecoxib or Placebo for Patients with Resected Stage III Colon Cancer.
View More »
Riverdale : Atlanta Colon and Rectal Surgery
A Prospective Study for the Assessment of Recurrence Risk in Stage II Colon Cancer Patients Using ColoPrint
Illinois
Elgin : Sherman Health
CTSU CALGB C80702 Phase III Randomized Study of Adjuvant FOLFOX Chemotherapy Comprising Oxaliplatin, Leucovorin Calcium, and Fluorouracil With Versus Without Celecoxib in Patients With Resected Stage III Colon Cancer
Elgin : Sherman Health
MDA 2009-0288 Randomized Pilot Study of Oncologist Recommended Home-Based Exercise Program Versus Relaxation Training for Physical Functioning and Symptom Control in Patients With Unresectable Stage IV or Recurrent Colon Cancer
Elgin : Sherman Health
NSABP P-5 Phase III Randomized Study of Adjuvant Rosuvastatin in Patients With Resected Stage I or II Colon Cancer
Indiana
Goshen : IUHealth Goshen Center for Cancer Care
Dose Finding Study of Twice Weekly IMMU-130 in Metastatic Colorectal Cancer
Indianapolis : Beltway Surgical Center
Narrow-Band Imaging Versus Standard White Light for the Detection of Serrated Lesions in the Proximal Colon
Missouri
St. Louis : Washington University
Adults 50 and older are needed for a cancer research study at Washington University.
New York
Bronx : Einstein-Montefiore Institute for Clinical & Translational Research
A Prospective Study for the Assessment of Recurrence Risk in Stage II Colon Cancer Patients Using ColoPrint
Bronx : Einstein-Montefiore Institute for Clinical & Translational Research
Clinical Investigation Plan STX 0206: Randomised Comparative Study of FOLFOX6m plus SIR-SpheresÒ Microspheres versus FOLFOX6m Alone as First Line Treatment in Patients with Non-Resectable Liver Metastases from Primary Colorectal Carcinoma
View More »
Bronx : Albert Einstein College of Medicine, Montefiore Medical Center
A Prospective Study for the Assessment of Recurrence Risk in Stage II Colon Cancer Patients Using ColoPrint
Bronx : Montefiore Medical Center - Moses Campus
Exploratory Study Of The ERCC-1 Gene
Bronx : Montefiore Medical Center - Weiler Campus
Exploratory Study Of The ERCC-1 Gene
North Carolina
Winston-Salem : Wake Forest University
A Prospective Study for the Assessment of Recurrence Risk in Stage II Colon Cancer Patients Using ColoPrint
Ohio
Cincinnati : ImClone Investigational Site
A Study of IMC-1121B or IMC-18F1 in Colorectal Cancer
Columbus : Ohio State University
A Prospective Study for the Assessment of Recurrence Risk in Stage II Colon Cancer Patients Using ColoPrint
South Carolina
Columbia : ImClone Investigational Site
A Study of IMC-1121B or IMC-18F1 in Colorectal Cancer
Tennessee
Nashville : ImClone Investigational Site
A Study of IMC-1121B or IMC-18F1 in Colorectal Cancer
Texas
Dallas : Mary Crowley Cancer Research Centers
Randomized Phase II Adjuvant Chemotherapy ± FANG™ in Colorectal Carcinoma With Liver Metastases
Houston : MD Anderson Cancer Center
A Prospective Study for the Assessment of Recurrence Risk in Stage II Colon Cancer Patients Using ColoPrint
Washington
Tacoma : Franciscan Research Center
A Prospective Study for the Assessment of Recurrence Risk in Stage II Colon Cancer Patients Using ColoPrint
Austria
Feldkirch : Landeskrankenhaus Feldkirch
A Prospective Study for the Assessment of Recurrence Risk in Stage II Colon Cancer Patients Using ColoPrint
Linz : Krankenhaus der Elisabethinen
A Prospective Study for the Assessment of Recurrence Risk in Stage II Colon Cancer Patients Using ColoPrint
Vienna : Medical University of Vienna
A Prospective Study for the Assessment of Recurrence Risk in Stage II Colon Cancer Patients Using ColoPrint
Canada
Calgary : ImClone Investigational Site
A Study of IMC-1121B or IMC-18F1 in Colorectal Cancer
Edmonton : ImClone Investigational Site
A Study of IMC-1121B or IMC-18F1 in Colorectal Cancer
Halifax : ImClone Investigational Site
A Study of IMC-1121B or IMC-18F1 in Colorectal Cancer
Hamilton : ImClone Investigational Site
A Study of IMC-1121B or IMC-18F1 in Colorectal Cancer
Kelowna : ImClone Investigational Site
A Study of IMC-1121B or IMC-18F1 in Colorectal Cancer
View More »
London : ImClone Investigational Site
A Study of IMC-1121B or IMC-18F1 in Colorectal Cancer
Mississauga : ImClone Investigational Site
A Study of IMC-1121B or IMC-18F1 in Colorectal Cancer
Montreal : ImClone Investigational Site
A Study of IMC-1121B or IMC-18F1 in Colorectal Cancer
Oshawa : ImClone Investigational Site
A Study of IMC-1121B or IMC-18F1 in Colorectal Cancer
Ottawa : ImClone Investigational Site
A Study of IMC-1121B or IMC-18F1 in Colorectal Cancer
Surrey : ImClone Investigational Site
A Study of IMC-1121B or IMC-18F1 in Colorectal Cancer
Toronto : ImClone Investigational Site
A Study of IMC-1121B or IMC-18F1 in Colorectal Cancer
Vancouver : ImClone Investigational Site
A Study of IMC-1121B or IMC-18F1 in Colorectal Cancer
Windsor : ImClone Investigational Site
A Study of IMC-1121B or IMC-18F1 in Colorectal Cancer
China
Hong Kong : University of Hong Kong/ Queen Mary Hospital
A Prospective Study for the Assessment of Recurrence Risk in Stage II Colon Cancer Patients Using ColoPrint
Denmark
Odense : Odense Universitetshospital
A Prospective Study for the Assessment of Recurrence Risk in Stage II Colon Cancer Patients Using ColoPrint
France
Montpellier : CRLC Val d'Aurelle-Paul Lamarque
A Prospective Study for the Assessment of Recurrence Risk in Stage II Colon Cancer Patients Using ColoPrint
Germany
Berlin : PAREXEL International Early Product Development Unit
Pharmacodynamic and Clinical Evaluation of Dose and Taste-optimised Low Volume PEG-based Bowel Cleansing Solutions Using the Split-dosing Intake Regimen in Healthy Subjects and in Subjects Undergoing Screening Colonoscopy
Munich : Klinikum Rechts Der Isar
A Prospective Study for the Assessment of Recurrence Risk in Stage II Colon Cancer Patients Using ColoPrint
Israel
Haifa : Elisha Medical Center
Polyp Detection With The Peerscope System™
Tel Aviv : Sourasky Medical Center
Clinical Study-evaluate Performance&Safety "Aer-O-Scope" in Colon of Low Risk Patients
Japan
Hamamatsu : Matsuda Hospital
A Prospective Study for the Assessment of Recurrence Risk in Stage II Colon Cancer Patients Using ColoPrint
Netherlands
Alkmaar : Medisch Centrum Alkmaar
A Prospective Study for the Assessment of Recurrence Risk in Stage II Colon Cancer Patients Using ColoPrint
Enschede : Medisch Spectrum Twente
A Prospective Study for the Assessment of Recurrence Risk in Stage II Colon Cancer Patients Using ColoPrint
Groningen : Martini Ziekenhuis
The Role of Surgery of the Primary Tumour With Few or Absent Symptoms in Patients With Synchronous Unresectable Metastases of Colon Cancer
Hoorn : Westfriesgasthuis
A Prospective Study for the Assessment of Recurrence Risk in Stage II Colon Cancer Patients Using ColoPrint
Leiden : LUMC
A Prospective Study for the Assessment of Recurrence Risk in Stage II Colon Cancer Patients Using ColoPrint
View More »
Nijmegen : Radboud University Nijmegen Medical Centre
The Role of Surgery of the Primary Tumour With Few or Absent Symptoms in Patients With Synchronous Unresectable Metastases of Colon Cancer
Rotterdam : St Franciscus Gasthuis
The Role of Surgery of the Primary Tumour With Few or Absent Symptoms in Patients With Synchronous Unresectable Metastases of Colon Cancer
Spain
Barcelona : Vall d' Hebron University Hospital
A Prospective Study for the Assessment of Recurrence Risk in Stage II Colon Cancer Patients Using ColoPrint
L'Hospitalet de Llobregat : IDIBELL Institut Catala d'Oncologia (ICO)
A Prospective Study for the Assessment of Recurrence Risk in Stage II Colon Cancer Patients Using ColoPrint
Sweden
Uppsala : Immunology Akademiska sjukhuset/ University Hospital
A Prospective Study for the Assessment of Recurrence Risk in Stage II Colon Cancer Patients Using ColoPrint
Switzerland
Baden : Kantonsspital Baden
A Prospective Study for the Assessment of Recurrence Risk in Stage II Colon Cancer Patients Using ColoPrint
United Kingdom
Norwich : Norfolk and Norwich University Hospital
A Prospective Study for the Assessment of Recurrence Risk in Stage II Colon Cancer Patients Using ColoPrint
Oxford : University of Oxford
A Prospective Study for the Assessment of Recurrence Risk in Stage II Colon Cancer Patients Using ColoPrint
